DMD and Duchenne muscular dystrophy: We previously showed that loss of sarcolemmal nNOSμ in the dystrophin-deficient muscles of mdx mice and in patients with DMD greatly impairs the normal NO-dependent attenuation of α-adrenergic vasoconstriction in exercising skeletal muscle, causing functional muscle ischemia [9]–[11].